NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma.
Pamela Becherini, Antonia Cagnetta, Sara Aquino, Claudia Martinuzzi, Debora Soncini, Moustafa S Ghanem, Michele Cea, Santina Bruzzone, Roberto Massimo Lemoli, Chandra Nagasuma, Axel Bellotti, Mario Passalaqua, Matteo Garibotto, Giulia Giorgetti, Elisa Gelli, Adithya Chedere, Francesco Ladisa, Claudia Veneziano, Francesco Piacente, Emanuele Angelucci, Silvia Ravera, Gianluca Santamaria, Fabio Guolo, Alessio Nencioni, Michel A Duchosal, Aimable Nahimana, Luca Mastracci, Fiammetta Monacelli
Blood advances 2025;9(5):1024-1039